As of 2026-03-17, the Relative Valuation of Cara Therapeutics Inc (CARA) is (240.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -4618.0%.
The range of the Relative Valuation is (164.99) - (247.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 17.8x | 16.4x |
| Forward P/E multiples | 9.9x - 15.9x | 14.6x |
| Fair Price | (164.99) - (247.18) | (240.36) |
| Upside | -3201.4% - -4746.3% | -4618.0% |
| Date | P/E |